...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: A meta-analysis and a systematic review of current evidence from comparative studies
【24h】

Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: A meta-analysis and a systematic review of current evidence from comparative studies

机译:根治性肾切除术与内窥镜手术治疗局限性上尿路上皮癌的比较:一项荟萃分析和对比较研究的最新证据的系统评价

获取原文
获取原文并翻译 | 示例

摘要

The conservative management of upper tract urothelial carcinoma (UTUC) has seen important developments over the last 10 years with advances in endoscopy. Our aim was to compare the available evidence regarding the impact of endoscopic nephron sparing procedures (NSP) and radical nephroureterectomy (RNU) on survival of upper tract urothelial carcinoma (UTUC). A critical review of Pubmed/Medline, Embase and the Cochrane Central Register of Controlled Trials was performed in July 2013 according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement. Overall, eight publications were selected for inclusion in this meta-analysis but all of them were retrospective or non-randomised comparative studies. The primary end points were the overall and cancer-specific survivals (OS and CSS) in the two treatment groups. We achieved to pool data on 1002 patients diagnosed with localised UTUC and treated either by endoscopic NSP (n = 322) or by RNU (n = 680). No significant difference was found in terms of OS and CSS between RNU and endoscopic NSP (HR = 1.47 and p = 0.31; HR = 0.96 and p = 0.91, respectively). However, the low level of evidence (3b) and the heterogeneity of the studies limited the quality of the results. In the absence of prospective and randomised studies, the equivalent oncologic control for endoscopic NSP and RNU is not provided by this meta-analysis. Multicentre prospective studies are urgently needed to assess the oncologic outcomes of UTUC with endoscopic management. In the next multicentre studies, the patients should be matched on the basis of the tumour stage (imaging) and grade (biopsy) at diagnosis. (C) 2014 Elsevier Ltd. All rights reserved.
机译:随着内窥镜检查的发展,近十年来,上尿路尿路上皮癌(UTUC)的保守治疗取得了重要进展。我们的目的是比较有关内镜保留肾单位术(NSP)和根治性肾切除术(RNU)对上尿路上皮癌(UTUC)生存的影响的现有证据。根据系统评价和荟萃分析的首选报告项目,2013年7月对Pubmed / Medline,Embase和Cochrane对照试验中央注册系统进行了严格审查。总体而言,选择了八篇出版物纳入该荟萃分析,但所有出版物均为回顾性或非随机比较研究。主要终点是两个治疗组的总体生存期和癌症特异性生存期(OS和CSS)。我们实现了对1002例诊断为局部UTUC并通过内镜NSP(n = 322)或RNU(n = 680)治疗的患者的数据汇总。在RNU和内镜NSP之间在OS和CSS方面没有发现显着差异(HR分别为1.47和p = 0.31; HR分别为0.96和p = 0.91)。但是,证据水平低(3b)和研究的异质性限制了结果的质量。在缺乏前瞻性和随机研究的情况下,该荟萃分析未提供对内镜NSP和RNU的等效肿瘤控制。迫切需要多中心前瞻性研究,以评估内镜治疗下UTUC的肿瘤学结局。在下一个多中心研究中,应根据诊断时的肿瘤分期(影像)和分级(活检)对患者进行匹配。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号